相关实验视频

Updated: Jul 28, 2025

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

Published on: January 29, 2021

在勒普托门病的诊断和治疗更新

Meaghan A Roy-O'Reilly¹, Tyler Lanman¹, Amber Ruiz¹

¹Department of Neurology, Stanford Medicine, Palo Alto, CA, 94305, USA.

Current oncology reports

|May 31, 2023

概括

勒普托门病 (LMD) 影响了晚期癌症患者. 新的CSF生物标志物和向疗法在LMD管理中显示出对诊断和改善存活率的承诺.

科学领域:

在瘤学瘤学.
神经学神经学
病理学病理学病理学

背景情况:

瘦骨关节疾病 (LMD) 是转移性癌症的一种严重并发症.
它与不良预后和有限的治疗策略有关.

研究的目的:

审查目前对LMD临床表现,病变发生,诊断和治疗的理解.
确定推动LMD研究和患者护理的机会.

主要方法:

关于LMD的最新文献的审查.
分析新兴的诊断和治疗方法.

主要成果:

可溶性脑脊液 (CSF) 生物标志物为LMD诊断提供了比细胞学更好的灵敏度.
向的小分子和内疗法改善了整体和无进展的生存率.
目前正在进行LMD的免疫疗法试验,显示出针对特定固体瘤的潜力.

结论:

脊髓瘤生物标志物在瘤诊断和管理方面显示出潜力.
针对性疗法对LMD患者显示出有前途的结果.
进一步的研究和临床试验的纳入对于推动LMD治疗至关重要.

关键词:

勒普托门关节疾病神经瘤学神经瘤学

更多相关视频

Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice

Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice

Published on: May 23, 2025

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

相关概念视频

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...